Literature DB >> 21979249

Sodium Tripolyphosphate: an excipient with intrinsic in vitro anti-Candida activity.

R Palmeira-de-Oliveira1, A Palmeira-de-Oliveira, C Gaspar, S Silvestre, J Martinez-de-Oliveira, M H Amaral, L Breitenfeld.   

Abstract

Sodium Tripolyphosphate (STPP) is a food additive that is being used in the development of micro and nanoparticles as it induces ionic interactions with chitosan molecules. Although the ability of STPP to inhibit the growth of several food contaminants has been reported, studies on its activity against clinical isolates are scarce. Candida spp. are common causative agents of mucocutaneous infections including the vulvovaginal tegument and new therapeutic approaches are needed in order to treat resistant and recurrent cases. The aim of this study was to evaluate in vitro both antifungal (anti-Candida spp.) activity, and cytotoxicity, on human dermal fibroblasts, of STPP solutions. STPP showed an inhibitory species-dependent activity against several Candida spp. strains being particularly active on C. glabrata, followed by C. guilliermondii. In vitro, STPP showed a concentration dependent cytotoxicity. Therefore STPP use, in low concentrations, seems to be interesting in the development of drug delivery systems for the treatment of vulvovaginal candidosis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979249     DOI: 10.1016/j.ijpharm.2011.09.030

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy.

Authors:  Bo Xiao; Hamed Laroui; Saravanan Ayyadurai; Emilie Viennois; Moiz A Charania; Yuchen Zhang; Didier Merlin
Journal:  Biomaterials       Date:  2013-06-29       Impact factor: 12.479

2.  Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages.

Authors:  Bo Xiao; Panpan Ma; Lijun Ma; Qiubing Chen; Xiaoying Si; Lewins Walter; Didier Merlin
Journal:  J Colloid Interface Sci       Date:  2016-11-26       Impact factor: 8.128

Review 3.  RNA interference-based nanosystems for inflammatory bowel disease therapy.

Authors:  Jian Guo; Xiaojing Jiang; Shuangying Gui
Journal:  Int J Nanomedicine       Date:  2016-10-12

Review 4.  siRNA Targeting and Treatment of Gastrointestinal Diseases.

Authors:  Rachel Chevalier
Journal:  Clin Transl Sci       Date:  2019-08-05       Impact factor: 4.689

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.